🇺🇸 Immune Globulin (Human) in United States

1,946 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 1,946

Most-reported reactions

1. Pruritus — 238 reports (12.23%)
2. Nausea — 230 reports (11.82%)
3. Headache — 227 reports (11.66%)
4. Pyrexia — 210 reports (10.79%)
5. Urticaria — 191 reports (9.82%)
6. Dyspnoea — 186 reports (9.56%)
7. Diarrhoea — 174 reports (8.94%)
8. Chills — 165 reports (8.48%)
9. Vomiting — 164 reports (8.43%)
10. Rash — 161 reports (8.27%)

Source database →

Frequently asked questions

Is Immune Globulin (Human) approved in United States?

Immune Globulin (Human) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Immune Globulin (Human) in United States?

Grifols Therapeutics LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.